Moderna to charge Rs 1855-Rs 2755 for COVID-19 vaccine: CEO

Henrietta Brewer
November 24, 2020

Meanwhile, as Brunei will be hosting the ASEAN Summit next year, Dato Seri Setia Dr Haji Mohd Isham said it is very unlikely the nation can host in-person meetings during the first half of the year because the vaccine will only be available during the first quarter of the year.

The State Task Force on COVID-19 recently met and reviewed preparations made for vaccine storage and delivery, he said.

Brussels has already struck deals with AstraZeneca, Pfizer-BioNTech, Sanofi-GSK, Johnson & Johnson and CureVac.

She said that the "The AstraZeneca vaccine is a viral vector vaccine".


AstraZeneca is lagging behind it speers given that it is still collecting and analysing data from the study, which could see the efficacy rate revised in future, hence the lukewarm reception to its initial vaccine results.

The government is now also in talks with Sinovac, through Henry Lim of the Federation of Filipino-Chinese Chambers of Commerce and Industry Inc.

Sinopharm's experimental COVID-19 vaccine uses an inactivated SARS-CoV-2 virus that is unable to replicate in human cells to trigger immune responses.

Brunei Darussalam is guaranteed a supply of the COVID-19 vaccine for 50 per cent of the population, while another 20 per cent are through direct negotiations with pharmaceutical companies, according to Minister of Health Dato Seri Setia Dr Haji Mohd Isham bin Haji Jaafar. "The real question is not whether the world can afford to share vaccines and other tools; it's whether it can afford not to", he said. USA pharmaceutical company Novavax is also developing a similar recombinant vaccine.


At least 80 percent of the private health facilities have also shared their data.

Meanwhile, a report in the Telegraph news site on Sunday said that Britain could give regulatory approval to Pfizer-BioNTech's Covid-19 vaccine this week, even before the USA authorises it. "They are not postpaid items, but prepaid". Countries around the world are also apparently in a race to bring out the most affordable vaccine.

In a news statement, the Senate President Pro Tempore also acknowledged that "one good development is that the adults in the [Duterte] Cabinet have gotten into the act, and I hope they will dictate the tempo and not the rank amateurs of PITC [Philippine International Trading Corp.] whose stint in office has so far been unblemished with success", adding, "Kung nahihirapan ngang bumili ng suka, bakuna pa kaya?". In addition to NBP2001, SK Bioscience is conducting the pre-clinical test of another vaccine candidate GBP510.


Other reports by iNewsToday

FOLLOW OUR NEWSPAPER